| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |